Tag: Biotech

Pahr Therapeutics secures $14M to develop PAH therapies

Pahr Therapeutics has raised $14 million in seed funding. This money will help develop new treatments for pulmonary…

Alloy Therapeutics, KSAC team up to grow Japan Biotechs

Alloy Therapeutics Co. Ltd. (Alloy Japan) signed a Memorandum of Understanding (MOU) with the Kansai Startup Academia Coalition…

NKGen and HekaBio team up on NK Cell therapy in Japan

NKGen Biotech, Inc. is a clinical-stage biotech firm. They focus on NK cell therapies, both autologous and allogeneic.…

Quantum Biology: Japan’s Role in the Next Medical Frontier

For many years, Japan has been a world leader in precision, innovation, and technology. Japan has always pushed…

DRC Medicine Ltd to Merge with Ribbon Acquisition Corp.

DRC Medicine Ltd., an innovative healthcare and biotechnology company based in Tokyo, Japan, announced that it has entered…

AGC Biologics Grows Cell Therapy Presence in Asia

AGC Biologics, your friendly CDMO expert, will commence cell therapy process development and clinical manufacturing services on July…

bitBiome Inc partners with leading CMO for Product Supply

bitBiome, Inc., a biotechnology company unlocking the potential of our planet's microbes to power the future of the…

Fujirebio Announces Strategic Collaboration with Stanford Medicine

Fujirebio, a leading innovator in in-vitro diagnostics, announced a collaboration with Stanford Medicine to advance research and innovation in…

ConcertAI Adds ASCO® Automation to AI Cancer Tools

ConcertAI, a leader in oncology generative and agentic AI SaaS and multi-modal data (MMD) solutions for healthcare and…

Cellares with Mitsui to Launch Japan’s First IDMO Factory

Cellares, a pioneer in automated cell therapy manufacturing, in collaboration with Mitsui Fudosan, announces the establishment of Japan’s…

Alloy Therapeutics Launches in Japan at Shonan iPark

Alloy Therapeutics Inc., a biotechnology ecosystem company dedicated to democratizing access to cutting edge drug discovery technologies, has…

RevolKa Raises $1.4M in Series A Extension for Therapies

RevolKa Ltd., a venture-backed biotech company providing a cutting-edge AI-driven protein engineering technology platform called aiProtein®, has raised…

Join Our Community

Join Our Community